Data for (Study ST000819)

(Analysis AN001300)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3
CL 62:1; [M-2H](2-)@5.51 0.5597 1.3449 1.0954
CL 64:1; [M-2H](2-)@9.34 0.9130 0.7899 1.2971
CL 66:1; [M-2H](2-)@9.58 0.9791 1.0132 1.0077
CL 66:2; [M-2H](2-)@9.39 1.0303 0.8286 1.1411
CL 66:3; [M-2H](2-)@5.66 0.4510 1.1703 1.3787
CL 66:3; [M-2H](2-)@9.19 0.9684 0.8277 1.2038
CL 66:4; [M-2H](2-)@8.96 1.3005 0.7709 0.9286
CL 68:1; [M-2H](2-)@9.81 1.0520 0.9181 1.0299
CL 68:2; [M-2H](2-)@9.57 1.1611 0.9100 0.9289
CL 68:3; [M-2H](2-)@9.44 0.9581 0.8851 1.1568
CL 68:4; [M-2H](2-)@9.22 1.0783 0.8384 1.0833
CL 68:5; [M-2H](2-)@9.02 1.0100 0.8971 1.0929
CL 70:1; [M-2H](2-)@6.11 0.8761 1.0226 1.1013
CL 70:2; [M-2H](2-)@9.83 1.1655 0.9224 0.9121
CL 70:3; [M-2H](2-)@9.61 1.1550 0.9131 0.9319
CL 70:4; [M-2H](2-)@9.47 0.9791 0.8845 1.1364
CL 70:5; [M-2H](2-)@9.28 0.8456 1.0190 1.1354
CL 70:6; [M-2H](2-)@9.10 1.1092 0.9590 0.9318
CL 72:2; [M-2H](2-)@10.02 1.2765 1.0042 0.7193
CL 72:3; [M-2H](2-)@9.86 1.0812 0.9750 0.9437
CL 72:4; [M-2H](2-)@9.69 1.1700 0.9073 0.9227
CL 72:5; [M-2H](2-)@9.52 1.0037 0.9753 1.0210
CL 72:6; [M-2H](2-)@9.32 1.0844 0.9551 0.9605
CL 72:7; [M-2H](2-)@9.18 1.1006 0.8984 1.0010
CL 72:8; [M-2H](2-)@8.97 1.1137 0.9542 0.9322
CL 74:11; [M-2H](2-)@5.57 0.7265 1.1171 1.1563
CL 74:1; [M-2H](2-)@6.58 0.8583 1.1139 1.0279
CL 74:5; [M-2H](2-)@9.74 0.9835 0.9940 1.0225
CL 74:6; [M-2H](2-)@9.57 0.9500 0.9362 1.1138
CL 74:7; [M-2H](2-)@6.01 0.8307 0.9873 1.1820
CL 74:7; [M-2H](2-)@9.40 1.2528 0.8905 0.8567
CL 74:9; [M-2H](2-)@5.64 0.7033 0.8712 1.4256
CL 76:8; [M-2H](2-)@9.44 0.9323 0.9005 1.1672
CL 76:9; [M-2H](2-)@9.30 1.1791 0.7689 1.0521
CL 78:11; [M-2H](2-)@9.67 1.6171 0.7727 0.6102
CL 78:13; [M-2H](2-)@5.71 0.8267 0.9357 1.2375
FFA(16:0) 1.0367 1.0274 0.9359
FFA(18:0) 1.0395 1.0312 0.9294
FFA(18:1) 0.9763 0.9638 1.0598
FFA(18:2) 1.1011 0.9675 0.9315
FFA(20:0) 1.0046 1.0473 0.9482
FFA(20:1) 0.9695 0.9246 1.1060
FFA(20:2) 1.0788 0.8760 1.0451
FFA(20:4) Arachidonic acid 1.0141 0.7224 1.2635
FFA(22:0) 0.9130 1.1202 0.9669
FFA(22:1) 1.0828 0.9382 0.9790
FFA(22:2) 0.9950 0.8799 1.1252
FFA(22:3) 0.8875 0.9844 1.1281
FFA(24:0) 1.1237 0.9724 0.9038
FFA(24:1) 1.0017 0.9249 1.0734
FFA(24:2) 1.2971 0.7243 0.9786
FFA(24:3) 1.0419 0.8165 1.1416
lysoPE 18:0; [M-H]-@2.40 0.6557 1.4519 0.8924
lysoPE 20:4; [M-H]-@1.29 1.1946 0.9091 0.8964
lysoPE 20:5; [M-H]-@1.08 1.0376 0.8349 1.1276
lysoPE 22:5; [M-H]-@1.48 1.2147 0.8332 0.9521
lysoPE 22:6; [M-H]-@1.24 1.2221 0.9147 0.8632
PE 32:0; [M-H]-@5.86 1.1930 0.7880 1.0190
PE 32:0; [M-H]-@6.67 0.7637 0.9277 1.3086
PE 33:0; [M-H]-@6.96 0.9795 1.0422 0.9783
PE 33:1; [M-H]-@6.51 0.7554 1.1177 1.1269
PE 34:3; [M-H]-@5.91 0.6446 1.1895 1.1658
PE 34:4; [M-H]-@5.67 0.5153 1.4367 1.0480
PE 35:0; [M-H]-@7.44 0.7543 1.2804 0.9653
PE 35:3; [M-H]-@6.14 0.7606 1.2241 1.0153
PE 36:0; [M-H]-@7.77 1.0647 1.0908 0.8444
PE 36:1; [M-H]-@7.35 0.8718 1.1513 0.9769
PE 36:6; [M-H]-@5.47 0.7688 1.0381 1.1932
PE 37:1; [M-H]-@7.46 0.8868 1.1097 1.0035
PE 37:3; [M-H]-@6.90 1.0187 0.9580 1.0233
PE 37:4; [M-H]-@6.63 0.8840 1.1441 0.9719
PE 38:2; [M-H]-@7.44 0.8749 1.2497 0.8755
PE 38:3; [M-H]-@7.17 0.8273 1.0833 1.0894
PE 38:7; [M-H]-@5.69 0.9131 0.8719 1.2149
PE 39:3; [M-H]-@7.28 1.0901 0.9723 0.9376
PE 39:4; [M-H]-@6.99 0.9574 1.2016 0.8410
PE 39:5; [M-H]-@6.60 0.9835 0.8797 1.1368
PE 39:6; [M-H]-@6.54 0.9348 0.9926 1.0726
PE 40:4; [M-H]-@7.27 1.0925 0.9859 0.9216
PE 40:8; [M-H]-@5.85 0.8834 1.1471 0.9696
PE 42:4; [M-H]-@7.73 0.9374 0.9442 1.1184
PE 42:7; [M-H]-@6.69 0.9776 1.0213 1.0011
PE 44:4; [M-H]-@8.49 1.3659 0.5661 1.0681
PG 32:0; [M-H]-@5.80 1.0617 0.8319 1.1064
PG 32:1; [M-H]-@5.23 0.9661 0.8459 1.1880
PG 33:0; [M-H]-@6.12 1.2252 0.8844 0.8904
PG 33:1; [M-H]-@5.62 1.0650 0.7270 1.2080
PG 34:1; [M-H]-@5.84 1.0264 0.9163 1.0573
PG 34:2; [M-H]-@5.25 0.9917 0.9540 1.0543
PG 34:3; [M-H]-@4.78 0.9191 0.9162 1.1646
PG 36:0; [M-H]-@6.95 0.9905 0.9861 1.0234
PG 36:1; [M-H]-@6.50 0.7615 0.9935 1.2450
PG 36:2; [M-H]-@5.70 0.8170 1.0321 1.1509
PG 36:3; [M-H]-@5.28 1.2339 0.8285 0.9376
PG 36:4; [M-H]-@4.89 1.2946 0.8457 0.8597
PG 36:5; [M-H]-@4.52 0.9980 0.8397 1.1622
PG 38:2; [M-H]-@6.63 0.8372 0.9770 1.1857
PG 38:3; [M-H]-@5.87 1.0996 0.9090 0.9914
PG 38:4; [M-H]-@5.53 0.8867 1.0617 1.0516
PG 38:5; [M-H]-@5.11 1.1345 0.8776 0.9879
PG 38:6; [M-H]-@4.81 1.1876 0.8141 0.9983
PG 38:7; [M-H]-@4.48 1.1214 0.7982 1.0804
PG 40:5; [M-H]-@5.62 1.5556 0.6793 0.7651
PG 40:6; [M-H]-@5.35 1.3339 0.8421 0.8239
PG 40:7; [M-H]-@5.05 0.9252 0.8754 1.1995
PG 40:8; [M-H]-@4.72 1.2596 0.8484 0.8920
PG 42:10; [M-H]-@4.63 1.1006 0.8114 1.0880
PG 42:7; [M-H]-@5.48 1.1319 0.5879 1.2803
PG 42:8; [M-H]-@5.32 1.2530 0.7069 1.0401
PG 42:9; [M-H]-@4.90 0.9586 0.9206 1.1208
PG 44:10; [M-H]-@5.16 1.3790 0.5958 1.0252
PG 44:11; [M-H]-@4.92 1.3952 0.5297 1.0751
PG 44:12; [M-H]-@4.58 1.0704 0.8974 1.0321
PG 44:9; [M-H]-@5.42 1.3217 0.7993 0.8790
PI 32:0; [M-H]-@5.63 0.9702 0.9582 1.0716
PI 32:1; [M-H]-@5.15 0.7297 0.9474 1.3229
PI 34:1; [M-H]-@5.73 1.0069 0.9708 1.0224
PI 34:2; [M-H]-@5.31 0.8437 1.1283 1.0281
PI 36:1; [M-H]-@6.35 0.8376 1.1502 1.0122
PI 36:2; [M-H]-@5.91 1.2155 0.8974 0.8870
PI 36:3; [M-H]-@5.51 0.9022 0.9523 1.1455
PI 36:4; [M-H]-@5.28 0.9566 0.8295 1.2139
PI 38:3; [M-H]-@6.15 0.9905 1.0239 0.9857
PI 38:4; [M-H]-@5.81 0.9383 1.0371 1.0246
PI 38:5; [M-H]-@5.46 0.8816 0.9497 1.1687
PI 38:6; [M-H]-@5.14 0.8020 0.8187 1.3793
PI 40:4; [M-H]-@6.34 0.9011 0.8497 1.2493
PI 40:5; [M-H]-@5.98 0.9909 1.0409 0.9681
PI 40:6; [M-H]-@5.82 1.0332 1.0729 0.8939
plasmenyl-PE 30:0; [M-H]-@6.40 1.2062 0.9608 0.8329
plasmenyl-PE 31:0; [M-H]-@6.62 1.0911 1.0175 0.8914
plasmenyl-PE 33:0; [M-H]-@7.17 1.1641 0.9241 0.9118
plasmenyl-PE 36:0; [M-H]-@8.08 0.9876 1.0132 0.9992
plasmenyl-PE 36:2; [M-H]-@7.24 0.9203 1.0626 1.0171
plasmenyl-PE 38:0; [M-H]-@8.50 0.7507 1.2102 1.0391
plasmenyl-PE 38:1; [M-H]-@8.11 0.9101 1.1272 0.9627
plasmenyl-PE 38:2; [M-H]-@7.74 0.8321 1.0621 1.1058
plasmenyl-PE 38:3; [M-H]-@7.44 1.0516 1.0194 0.9290
plasmenyl-PE 38:4; [M-H]-@7.17 0.9245 1.0149 1.0606
plasmenyl-PE 38:5; [M-H]-@6.70 1.1377 0.8541 1.0082
plasmenyl-PE 38:6; [M-H]-@6.50 1.1341 0.7645 1.1014
plasmenyl-PE 40:1; [M-H]-@8.54 0.8527 1.0452 1.1022
plasmenyl-PE 40:4; [M-H]-@7.60 0.9160 1.0346 1.0494
plasmenyl-PE 40:6; [M-H]-@7.12 0.8890 0.9782 1.1327
plasmenyl-PE 42:4; [M-H]-@8.00 1.1028 0.9809 0.9163
plasmenyl-PE 42:5; [M-H]-@7.81 1.0703 1.0527 0.8770
plasmenyl-PE 42:6; [M-H]-@7.69 0.9763 1.1054 0.9183
PS 32:1; [M-H]-@5.25 0.7254 1.0541 1.2205
PS 34:1; [M-H]-@5.89 0.7735 1.1503 1.0762
PS 34:2; [M-H]-@5.41 0.9561 1.1698 0.8741
PS 36:1; [M-H]-@6.43 0.8493 1.1025 1.0482
PS 36:2; [M-H]-@5.93 0.9603 1.0942 0.9454
PS 36:3; [M-H]-@5.65 1.1248 1.0320 0.8432
PS 36:4; [M-H]-@5.38 0.9682 0.8036 1.2282
PS 38:2; [M-H]-@6.56 0.7998 1.1362 1.0640
PS 38:3; [M-H]-@6.24 0.8928 1.1309 0.9763
PS 38:4; [M-H]-@5.94 0.7534 1.2144 1.0322
PS 38:5; [M-H]-@5.48 1.0335 0.9247 1.0418
PS 38:6; [M-H]-@5.28 0.8962 1.1852 0.9186
PS 40:1; [M-H]-@7.52 0.8611 1.1640 0.9750
PS 40:2; [M-H]-@7.04 1.0068 0.9527 1.0406
PS 40:4; [M-H]-@6.44 1.0034 0.9937 1.0029
PS 40:5; [M-H]-@6.08 1.0074 0.9505 1.0421
PS 40:6; [M-H]-@5.89 0.8120 1.1128 1.0752
PS 42:1; [M-H]-@8.04 0.9086 0.7679 1.3235
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Transduced with:shACADM4
F2Transduced with:shACADM6
F3Transduced with:shACADMscr
  logo